Biological activity of IL-2 and IL-7 in vivo is significantly increased when complexed with some of the respective anti-cytokine mAb. Different immune cell subsets can be preferentially stimulated depending on the anti-IL-2 mAb used to complex IL-2. IL-2/anti-IL-2 mAb S4B6 immunocomplexes (IL-2/S4B6) induce preferential expansion of CD122high cells whereas IL-2/anti-IL-2 mAb JES6-1 immunocomplexes (IL-2/JES6-1) highly selectively stimulate CD25high cells in mice. Similarly, IL-7/anti-IL-7 mAb M25 immunocomplexes (IL-7/M25) possess higher stimulatory activity for both naïve and memory CD8+ T cells in vivo in comparison to free IL-7. CTLA-4 and PD-1 molecules are inhibitory receptors which negatively regulate proliferation, survival and effector functions of T cells. Blocking antibodies against these molecules represent promising immunotherapeutic tool for treatment of malignant diseases. We examined possible synergism of IL-2/S4B6 and αCTLA-4 plus αPD-1 mAbs in tumor-bearing mice. We found that the expansion of recently activated CD8+ T cells driven by IL-2/S4B6 was further augmented by αCTLA-4 plus αPD-1 mAbs. However, these two immunotherapeutic approaches did not show synergistic antitumor activity in any mouse tumor model tested. Next, we showed that IL-7/M25 possessed higher biological activity...

Eines der prävalentesten humanen Pathogene ist das Magenbakterium Helicobacter pylori, welches ca. die Hälfte der Weltbevölkerung infiziert. Die Persistenz geht mit einer chronischen Gastritis einher, welche bis zu Magenkrebs fortschreiten kann. H.pylori bedient sich diverser Mechanismen um sich der Erkennung des Immunsystems zu entziehen und somit eine chronische Infektion zu ermöglichen. Erhöhte Expression des Immunzellinhibitors PD-L1 wurde in Magenepithelzellen gefunden, welche mit diesem Gram-negativen Erreger infiziert wurden. In dieser Arbeit wurde die Regulation auf in vitro Ebene untersucht, wobei zwei unterschiedliche Mechanismen identifiziert wurden. Ursächlich für die frühe PD-L1-Induktion ist die ADP-heptose/ALPK1 Signalkaskade. Der bakterielle Metabolit ADP-heptose, welcher für die Bildung von LPS benötigt wird, wurde als PAMP identifiziert, welcher durch das Sekretionssystems cagT4SS in die infizierte transportiert und anschließend von der Host Kinase ALPK1 erkannt wird. Gegensätzlich hierzu, wurde festgestellt, dass die zweite PD-L1-Hochregulation auf der metabolischen Reprogrammierung des Wirts beruht. Ein Merkmal von H. pylori ist dessen Bedarf an Cholesterin, welches es aus dem Medium oder aus membranösen Lipidregionen des Wirts extrahiert wird. Es konnte bewiesen werden, dass dieser Sterol-Abbauprozess zu einer erhöhten Stoffwechselaktivität führt, die spezifisch mit einer Zunahme der Glykolyse verbunden ist und mit einer Expressionsverschiebung des ersten Glykolyseenzyms Hexokinase von der Isoform 1 zu 2 einhergeht. Knockdown und Knockout- Experimente wiesen auf einen Zusammenhang mit der Regulation des Immunzellinhibitoren PD-L1 hin. / One of the most prevalent bacteria is the gastric bacterium Helicobacter pylori, which infects half of the world’s population. Persistence is accompanied with chronic gastritis which can progress towards gastric cancer. Several strategies are used by H.pylori to evade the immune system, enabling chronic infection. Heightened expression of the immune cell inhibitor PD-L1 was found in gastric epithelial cells, infected with this Gram-negative pathogen. Within this thesis, upregulation was studied in in vitro models, revealing two distinct mechanism. Causative for early PD-L1 induction is the ADP heptose/ALPK1 signaling axis. The bacterial metabolite ADP heptose, which is needed for LPS synthesis, was identified as PAMP, which is transported through the secretion system cagT4SS into the infected cell and is recognized by the host kinase ALPK1. In contrast, late upregulation of PD-L1 was found to be linked to metabolic reprogramming upon infection. Characteristic to H.pylori is its need of cholesterol, which it has to extract from the surrounding medium or lipid-rich regions within the host membrane. It could be shown that this sterol extraction process is accompanied with an increased metabolic activity which is linked with enhanced glycolysis and an expression shift of the glycolytic enzyme hexokinase isoform 1 to 2. Knockdown and knockout experiments showed a link between HK2 and regulation of the immune checkpoint PD-L1.

Multi-metallic aerogels have emerged as a promising unsupported, high surface area-based metal material for different applications in heterogeneous catalysis and electrochemistry. The fabrication of these multi-metallic aerogels is based on a complex gelation process which is characterized by controlled aggregation of metallic nanoparticles to form a macroscopic network structure in aqueous solution. However, achieving structural homogeneity of the multi-metallic aerogels in terms of diameter of the nanochains and chemical composition at the nano- as well as at the macro-scale is still a great challenge. In this paper, we show the characterization of two Pd-Pt aerogels prepared by the two-step gelation method. The structural homogeneity and chemical distribution of both metals (Pd and Pt) inside the aerogels were analyzed using high-resolution (scanning) transmission microscopy (HR(S)TEM), energy-dispersive X-ray spectroscopy (EDX), extended X-ray absorption fine structure (EXAFS) spectroscopy, and cyclic voltammetry. Based on the microscopic and spectroscopic results, the Pd-Pt aerogels show the presence of Pd/Pt-rich domains inside the long-range framework. It is evident that the initial monometallic features dominate over alloying during the gelation process. Although the same synthetic approach for Pd-Pt aerogels with different atomic ratios was used, we observed that the sizes of these monometallic domains strongly varied between the Pd-rich and Pt-rich aerogels. For instance, the Pd-rich aerogels showed larger clusters with a size range from few nanometers up to several tens of nanometers, while the dimension of the clusters of the Pt-rich aerogels varies from the sub-nanometers to a few nanometers. The presence of the metal clusters strongly influenced the electrochemical robustness of these Pd-Pt aerogels. Electrochemical durability investigations revealed that the aerogels with a high content of Pd are less stable due to the gradual dissolution of the less noble metal in particular inside the Pd-rich domains. A better chemical and structural homogeneity might improve the life-time of the Pd-Pt aerogels under electrochemical conditions. In this work, we provide a better understanding about the structure and chemical distribution of the bimetallic aerogel framework prepared by the two step gelation process.

In the nearest future, the human driver is viewed as a reliable backup even for the fully automated road motor vehicles (cars). Indeed, the driver is assumed to swiftly take the control of the car in cases of suddenly occurring (i) challenging environmental conditions, (ii) complex unforeseen driving situations, or (iii) degradation of performance of the car. However, due to the cognitive overload in such a sudden, stressful takeover of the control, the driver would often experience the startle effect, which usually results in an unconscious, instinctive, yet incorrect response. An extreme case of startle is freezing, in which the driver might be incapable to respond to the sudden takeover of control at all. The possible approaches to alleviate the startle during the takeover of control (i.e., the automation startle) include an offset- (i.e., either early- or delayed-), gradual yielding the controls to the driver. In the cases considered above, however, these approaches are hardly applicable because of (i) the presumed unpredictability of the events that result in the need of takeover of control, and (ii) the severe time constraints of the latter. Conversely, the objective of our research is to propose an approach of minimizing the need of yielding the control to the driver in challenging environmental conditions by guaranteeing an adequate automated control in these conditions. Focusing on slippery roads as an instance of challenging conditions, and steering control as an instance of control, we aim at developing such an automated steering that controls the car adequately in various road surfaces featuring low friction coefficients without the need of driver’s intervention.In order to develop such an automated steering we employed an in-house evolutionary computation framework – XML-based genetic programming (XGP) – which offers a flexible, portable, and human readable representation of the evolved optimal steering functions. The trial runs of the evolved steering functions were performed in the Open Source Racing Car Simulator (TORCS), which features a realistic, yet computationally efficient simulation of the car and its environment. The obtained experimental results indicate that due to the challenging dynamics of the unstable car on slippery roads, neither the canonical (tuned) servo-control (as a variant of PD) nor the (tuned) PID-controller could control the car adequately on slippery roads. On the other hand, the controller, featuring a relaxed, arbitrary structure evolved by XGP outperforms both the servo- and PID controllers in that it results in a minimal deviation of the car from its intended trajectory in rainy, snowy, and icy road conditions. Moreover, the evolved steering that employs anticipated perceptions is even superior as it could anticipate the imminent understeering of the car at the entry of the turns and consequently – to compensate for such an understeering by proactively turning the steering wheels in advance – well before entering the turn. The obtained results suggest a human competitiveness of the evolved automated steering as it outperforms the commonly used alternative steering controllers proposed by human experts. The research could be viewed as a step towards the evolutionary development of automated steering of cars in challenging environmental conditions. / 博士(工学) / Doctor of Philosophy in Engineering / 同志社大学 / Doshisha University

À la lumière du changement climatique et de l'épuisement des réserves de combustibles fossiles, l'innovation dans les technologies énergétiques vertes et durables devient un défi crucial. La fabrication de produits chimiques consomme de grandes quantités d'énergie et est responsable d'une part importante des émissions mondiales de carbone. Dans ce contexte, l'électrosynthèse, alimentée par de l'électricité renouvelable, peut remplacer de nombreux procédés thermochimiques industriels pour générer des carburants, des produits chimiques et des engrais. Plutôt que de nous concentrer sur des domaines qui ont reçu beaucoup d'attention ces dernières années (par exemple, l'électrolyse de l'eau et la réduction du CO2), nous avons exploré les domaines émergents de l'électrosynthèse hétérogène pour lesquels il existe un besoin substantiel. Dans le chapitre 3, nous soulignons l'importance de concevoir des électrocatalyseurs avec des sites actifs bien définis. Nous rapportons l'utilisation de la chimie réticulaire pour concevoir un système de modèle électrocatalytique à base d'organo-métallique conducteur avec des sites actifs moléculaires M-O4 pour l'oxydation électrochimique du 5-hydroxyméthylfurfural (HMFOR). L'activité des MOF portant des sites actifs Ni-O4 (Ni-CAT) et Co-O4 (Co-CAT) a été analysée avec des techniques spectroscopiques électrochimiques et operando pour élucider le mécanisme de réaction se produisant à la surface. Les expériences électrochimiques révèlent que le Co-CAT a un potentiel d'apparition plus précoce pour activer le HMFOR, par rapport à la plupart des catalyseurs établis, tandis que le Ni-CAT présente une cinétique plus rapide pour la conversion du 5-hydroxyméthylfurfural (HMF) en acide 2,5-furandicarboxylique (FDCA) . Nous avons déterminé que Ni-CAT atteignait des rendements de FDCA (notre molécule cible) de 98,7 %. L'efficacité faradique peut atteindre 86,8% d'efficacité faradique. La spectroscopie infrarouge indique le HMF avec un groupe aldéhyde lié à la surface comme intermédiaire clé dans le cycle catalytique, qui se forme une fois que l'oxydation M (II \ III) se produit. Ce travail illustre l'avantage d'utiliser des sites actifs moléculairement définis couplés à la spectroscopie operando pour fournir des informations fondamentales sur une variété de réactions électrosynthétiques et ouvrir la voie à la conception future de catalyseurs. Suite à ce projet, nous nous sommes tournés vers l'utilisation d'un réacteur à membrane sélective pour l'hydrogène afin d'explorer de nouveaux concepts de réaction et de catalyseurs. La clé ici était d'utiliser une feuille de Pd comme matériau qui réduisait les protons en *H dans un compartiment aqueux et transférait l'hydrogène dans un compartiment organique où il hydrogénait le réactif de choix. À l'aide d'un réacteur à membrane, nous avons pu séparer physiquement la réduction électrochimique de l'hydrogène et la chimie de l'hydrogénation d'une manière qui contournait l'utilisation du gaz H2 qui serait autrement nécessaire. Nous choisissons comme point de départ un produit chimique produit industriellement en excès, l'acétonitrile. Le réacteur à membrane Pd est appliqué pour hydrogéner complètement la liaison C≡N de l'acétonitrile. Avec succès, nous avons obtenu de l'ammoniac et de l'acétaldéhyde comme produits de réaction à un potentiel de début record de 0,4 V vs Ag/AgCl. Enfin, en concevant soigneusement une cellule spectroélectrochimique unique, nous avons pu effectuer des mesures spectroscopiques infrarouges pour visualiser le processus de réaction dans la membrane Pd et par conséquent proposé un mécanisme unique de réaction d'hydrolyse de l'imine (Chapitre 4). Dans le chapitre 5, nous choisissons d'innover dans un domaine émergent : la formation de liaisons électrochimiques C-N à partir de réactifs de petites molécules (par exemple CO2, NH3). Le mécanisme conventionnel de formation de liaisons électrochimiques C-N est basé sur le CO2RR électrochimique. Dans ce chapitre, nous proposons une stratégie orthogonale pour activer simultanément le CO2 et les N-réactifs en appliquant respectivement des impulsions de potentiel négatives et positives. Les nanoparticules de Cu sont utilisées comme catalyseur modèle, le CO2 agit comme réactif C et le NH3 agit comme réactif N pour le couplage C-N. Dans des conditions optimisées dans lesquelles la couverture *NH2 est maintenue à l'état stable tandis que Cu reste métallique, l'électrolyse pulsée augmente à la fois le taux de formation et la sélectivité des produits C-N urée, formamide et acétamide de 3 à 20 fois. En étendant le champ d'application à des réactifs C et N supplémentaires, ainsi qu'au couplage C-S, cette nouvelle approche démontre davantage sa valeur générale en électrosynthèse. / In light of climate change and depleting fossil fuel reserves, innovating green and sustainable energy technologies becomes a critical challenge. Chemical manufacturing consumes large amounts of energy and is responsible for a substantial portion of global carbon emissions. Against this backdrop, electrosynthesis, powered by renewable electricity, can replace many industrial thermochemical processes to generate fuels, chemicals, and fertilizers. Rather than focusing on areas that have received much attention in recent years (e.g. water electrolysis and CO2 reduction), we explored emerging areas within heterogeneous electrosynthesis for which there is a substantial need. In chapter 3, we highlight the importance of designing electrocatalysts with well defined active sites. We report the use of reticular chemistry to design a conductive metal organic framework-based electrocatalytic model system with molecular M-O4 active sites for electrochemical oxidation of 5-hydroxymethylfurfural (HMFOR). The activity of MOFs bearing Ni-O4 (Ni-CAT) and Co-O4 (Co-CAT) active sites were analyzed with electrochemical and operando spectroscopic techniques to elucidate the reaction mechanism occurring on the surface. Electrochemical experiments reveal that Co-CAT has an earlier onset potential for enabling HMFOR, relative to most established catalysts, while the Ni-CAT shows faster kinetics for the conversion of 5-hydroxymethylfurfural (HMF) to 2,5-furandicarboxylic acid (FDCA). We determined that Ni-CAT achieved FDCA (our target molecule) yields of 98.7% yield. The faradic efficiency can reach out to 86.8% faradic efficiency. Infrared spectroscopy points to HMF with a surface-bound aldehyde group as the key intermediate in the catalytic cycle, which forms once the M(II\III) oxidation occurs. This work illustrates the advantage of utilizing molecularly defined active sites coupled with operando spectroscopy to provide fundamental insights into a variety of electrosynthetic reactions and pave the way for future catalyst design. Following this project, we turned to the use of a hydrogen-selective membrane reactor to explore more new reaction and catalysts concepts. The key here was using a Pd foil as a material that reduced protons to *H at an aqueous compartment and transferred the hydrogen through to an organic compartment where it hydrogenated the reactant of choice. Using a membrane reactor, we could physically separate electrochemical hydrogen reduction and hydrogenation chemistry in a manner that circumvented the use of H2 gas as would otherwise be necessary. We choose a chemical that is industrially produced in excess, acetonitrile, as a starting point. The Pd membrane reactor is applied to fully hydrogenate the C≡N bond of acetonitrile. Successfully, we obtained ammonia and acetaldehyde as reaction products at a record onset potential of 0.4 V vs Ag/AgCl. Finally, by carefully designing a unique spectroelectrochemical cell, we were able to carry out infrared spectroscopic measurements to visualize the reaction process in Pd-membrane and consequently proposed a unique imine-hydrolysis reaction mechanism (Chapter 4). In Chapter 5, we choose to innovate in an emerging area: electrochemical C-N bond formation from small molecule reactants (e.g. CO2, NH3). The conventional electrochemical C-N bond formation mechanism is based on electrochemical CO2RR. In this chapter, we propose an orthogonal strategy to simultaneously activate CO2 and N-reactants by applying negative and positive potential pulses, respectively. Cu nanoparticles are used as a model catalyst, CO2 acts as the C-reactant, and NH3 acts as the N-reactant for C-N coupling. Under optimized conditions in which *NH2 coverage is maintained at steady state while Cu remains metallic, pulsed electrolysis increases both the rate of formation and the selectivity of the C-N products urea, formamide and acetamide by 3-20 times. By extending the scope to additional C- and N-reactants, as well as C-S coupling, this new approach further demonstrates its general value in electrosynthesis.

Immunotherapy, especially the adoptive transfer of T cells and immune checkpoint blockade therapy, have revolutionized cancer therapy. In particular, utilizing antigen-specific T cells for adoptive cell therapy has enabled the development of specific and effective strategies. It has paved the way for developing more accurate and personalized cancer immunotherapies. Adoptive cell therapy (ACT) results depend on the characteristics of ex vivo expanded T cells, such as their differentiation and clonal diversity. However, ex vivo expanded specific T cells often express several inhibitory receptors involved in T-cell exhaustion and markers of terminal effector differentiation. Accordingly, we hypothesized that blocking one or several inhibitory receptors during the ex vivo expansion could improve the expansion and differentiation of antigen-specific T cells. Preconditioning the ACT products and combinatorial immunotherapy approaches are newly developed concepts in cancer therapy to optimize cancer immunotherapy for a larger group of patients. To study the development of antigen-specific T-cells in combination with checkpoint blockade, we have adopted a method that allows the expansion of rare antigen-specific T cell precursors from PBMCs via multiple stimulations, using antigen-pulsed dendritic cells. In the current study, we utilized our protocol to generate and expand antigen-specific CD8+ T cells targeting the oncogenic Epstein-Barr virus (EBV)-LMP2 and a tumor-associated antigen (TAA) from the Wilms Tumor 1 (WT1) protein. We employed two approaches to abolish the negative regulatory receptors, antibody-mediated blockade and deletion via CRISPR/Cas9. We evaluated the impact of checkpoint blockade on antigen-specific T cells development, proliferation, and function. Additionally, TCR clonality and transcriptomic changes were assessed by genomic studies, including single-cell RNA (scRNA) sequencing and T-cell receptor sequencing. Supporting our hypothesis, we observed that blocking both PD-L1 and TIM3 (not any of them alone) significantly enhanced LMP2 and WT1-specific T cell generation and expansion. Additionally, checkpoint blockade resulted in higher specific T cell function, including cytokine production and in vitro targeted cytotoxicity. Using scRNA-seq and TCR sequencing approaches, we first remarked that the specific T cells are highly oligoclonal and identified a few dominant shared clones between donors. Immune checkpoint blockade did not confer consistent transcriptional signatures but may have a clonotype and donor-specific impact on the expression of activation and exhaustion-related genes. Overall, immune checkpoint blockade did not markedly alter the clonal composition of the T-cell product. We also evaluated the impact of CD5 deletion in antigen-specific T cell priming and expansion as an inhibitory receptor and a part of the immune response synapse. However, in a human ACT setting, our data show that the CRISPR/Cas9 mediated CD5 deletion only has modest effects on antigen-specific T-cell generation. However, future combinations with the blockade of other immune checkpoint may be warranted. Conclusion We demonstrated that blocking PD-L1 and TIM3 during the ex vivo expansion improves antigen-specific T-cell yield. We show that blocking multiple checkpoints can synergistically optimize specific T-cell production without compromising the response's specificity. It is a rapidly implementable strategy to enhance the number and quality of ex vivo expanded antigen-specific T cells for immunotherapy. / Le transfert adoptif de cellules T et le traitement par le blocage des points de contrôle immunologiques ont révolutionné le traitement du cancer. En particulier, l'utilisation de cellules T antigène-spécifiques en thérapie cellulaire adoptive a facilité le développement d'immunothérapies anticancéreuses plus précises et personnalisées. Les résultats de la thérapie cellulaire adoptive (TCA) sont liés à la qualité des cellules T spécifiques expansées ex vivo, telles que leur état de différenciation et leur diversité clonale. Cependant, le pré-conditionnement des produits de thérapie cellulaire adoptive et les traitements d'immunothérapie combinatoire sont de nouveaux concepts en développement de la thérapie du cancer pour optimiser l'immunothérapie du cancer dans un plus grand groupe de patients. Nous avons formulé l’hypothèse que le blocage d'un ou plusieurs récepteurs inhibiteurs au cours de l'expansion ex vivo favorise une meilleure expansion et une meilleure fonction des cellules T destinées à la TCA. Pour étudier l’expansion et la différenciation de cellules T antigène-spécifiques lors d’un blocage des points de contrôle, nous avons adopté une méthode qui nous permet de stimuler et expanser de rares cellules T antigène-spécifiques à partir de cellules mononuclées du sang périphérique (PBMCs) via de multiples stimulations utilisant des cellules dendritiques chargées avec l’antigène d’intérêt. Nous avons utilisé deux approches pour supprimer l’activité des récepteurs régulateurs négatifs, les anticorps bloquants des points de contrôle et la délétion génique via CRISPR/Cas9. Nous démontrons que le blocage combiné de PD-L1 et TIM3 améliore considérablement la l'expansion de cellules T CD8+ spécifiques à des antigènes viraux et tumoraux. De plus, le blocage des points de contrôle a entraîné la génération de cellules T spécifiques fonctionelles tel que démontré par la production de cytokines et la cytotoxicité in vitro. En utilisant de séquençage de l'ARN en cellule unique (scRNA-seq) et de séquençage des récepteurs des lymphocytes T (TCP-seq), nous avons remarqué que les cellules T spécifiques sont très fortment oligoclonales. Nous avons également identifié quelques clones dominants partagés entre les donneurs. L’application de l’inhibition des points de controles ne confère pas de signatures transcriptionelles particulières mais pourrait affecter certains clones provenant de certains donneurs davantage que d’autres. De plus, le peu de changements dans la composition clonale des cellules expandues suggèrent que le blocage de ces points de contrôle immunologiques n’altère pas de façon significative le produit cellulaire obtenu. Des données récentes soutiennent également un rôle du CD5 dans la régulation de l'activation des cellules T naïves et leur état fonctionnel. Cependant, dans un contexte compatible avec la TCA, nos données montrent que la suppression de CD5 via CRISPR/Cas9 n'a que des effets modestes sur la génération de cellules T antigène-spécifiques. Par contre, la combinaison éventuelle avec l’inhibition de d’autres points de contrôle immunologiques pourrait être envisagée. En conclusion, nos travaux fournissent une nouvelle méthode pour générer des cellules T spécifiques pour la TCA et la caractérisation à plus haute résolution de cellules T spécifiques expansées ex vivo. Nous avons donc démontré que le blocage combiné de plusieurs points de contrôle peut optimiser de manière synergique la production de cellules T spécifiques sans compromettre la spécificité de la réponse. Il s'agit là d'une stratégie rapidement applicable pour améliorer le nombre et la qualité des cellules T antigène-spécifiques expansées ex vivo pour l'immunothérapie.

[pt] Os ciclos termoquímicos de decomposição de água relacionados ao enxofre são uma importante classe de processos químicos considerados para a produção de hidrogênio. Recentemente, a decomposição térmica do sulfato de magnésio e sulfato de amônio tem sido relatada como uma potencial operação unitária em um desses ciclos. Portanto, algum interesse tem sido observado no uso de catalisadores para diminuir a energia de ativação de sulfatos que se decompõem em altas temperaturas, como o magnésio e a adição de um agente modificador para facilitar a separação dos produtos no caso de sulfatos que se decompõem em baixas temperaturas como amônio. Neste contexto, a presente tese relata os resultados da modelagem termodinâmica e cinética associada a este sistema de reação na presença de Pd suportado sobre gama-Al(2)O(3). Para o sistema Mg a presença de tais espécies é responsável por deslocar a temperatura de decomposição para valores mais baixos em pelo menos 100 graus C. Observou-se que o teor de magnésio ainda está orientado para a formação de MgO. Os resultados obtidos indicam que o catalisador Pd/Al(2)O(3) pode ser uma boa alternativa na redução da temperatura de decomposição térmica, pois sua presença foi responsável por diminuir a energia de ativação do processo de 368,2 para 258,8 kJ.mol(-1). Para o sistema NH4 pode-se observar que ocorre em quatro etapas e a formação de sulfato de alumínio, sendo a última espécie portadora de sulfato, proporciona a separação do óxido de enxofre liberando-o em uma etapa diferente dos demais produtos gasosos. A presença de paládio pode atuar como redutor da energia de ativação desta etapa, deslocando a temperatura de decomposição para valores inferiores em pelo menos 90 graus C e a reduzindo os valores de energia de ativação entre 12 – 30 por cento abaixo do encontrado na literatura oriundos de modelos gráficos. / [en] The sulfur related thermochemical water-splitting cycles are an important class of chemical processes considered for hydrogen production. Recently, the magnesium and the ammonium sulfate thermal decomposition have been reported as a potential unit operation in one of these cycles. Therefore, some interest has been observed in the use of catalysts to lower the activation energy for sulfates that decompose in high temperatures, as such magnesium and the addition of a modifying agent to facilitate separation of the products in the case of sulfates that decompose into low temperatures as ammonium. In this context, the present thesis reports the thermodynamics and kinetics modeling results associated with this reactions systems in the presence of a Pd supported over gamma-Al(2)O(3). For Mg system the presence of such species is responsible for shifting the decomposition temperature to lower values in at least 100 degrees C. It was observed that the magnesium content is still oriented towards MgO formation. The obtained results indicate that the Pd/Al(2)O(3) catalyst could be a good alternative in reducing the thermal decomposition temperature as its presence was responsible for diminishing the process activation energy from 368.2 to 258.8 kJ.mol(-1). For NH(4) system it can be observed four steps for reactions and formation of aluminum sulfate, as the last sulfate bearing species, provided the separation of the sulfur oxide releasing it in a different step from the other gaseous products. The presence of palladium can act as an activation energy reducer, shifting the decomposition temperature to lower values in at least 90 degrees C and decreasing the activation energy by 12 – 30 percent than that found in the literature.

[ES] La presente tesis doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el diseño, síntesis, caracterización y evaluación de nuevos nanodispositivos híbridos orgánico-inorgánicos. En concreto, se han desarrollado nanopartículas de sílice mesoporosas (MSNs) y nanopartículas Janus combinando MSNs con platino y con oro con el objetivo de mejorar los tratamientos anti-tumorales. El primer capítulo es una introducción general que incluye una visión global del contexto en el que se enmarca la investigación realizada. En particular, se incluye información básica sobre los diferentes tipos de nanopartículas empleados en esta tesis doctoral, así como la descripción de la enfermedad del cáncer y la aplicación de los nanomateriales como terapia. A continuación, en el segundo capítulo, se presentan los objetivos generales y específicos de esta tesis doctoral. Los capítulos tercero y cuarto describen dos estrategias terapéuticas basadas en el desarrollo de nanopartículas con movimiento para mejorar la terapia antitumoral. Concretamente, en el primer capítulo experimental se presenta un nanodispositivo autopropulsado para la liberación controlada de fármacos en respuesta al glutatión (GSH) intracelular. Éste se basa en nanopartículas tipo Janus compuestas por sílice mesoporosa y oro, funcionalizadas en la parte del oro con la enzima catalasa, cargadas con doxorrubicina y con cadenas de oligo(etilenglicol) (S-S-PEG) unidas por puentes disulfuro en la cara de la sílice. Una vez sintetizado y caracterizado el dispositivo, se confirmó su movimiento y se demostró el funcionamiento de la puerta molecular. Finalmente, la internalización celular y la liberación de doxorrubicina se estudiaron en cultivos celulares. Motivados por los resultados anteriores, en el cuarto capítulo se describe un nuevo nanomotor diseñado como tratamiento antitumoral y similar al anterior. En este caso, la nanopartícula Janus desarrollada está compuesta por una nanopartícula de sílice mesoporosa junto con una de platino, cargada con doxorrubicina y cubierta con S-S-PEG. Al igual que en el trabajo anterior, se consigue la autopropulsión del dispositivo. Además, se obtuvo el perfil cinético de liberación del cargo en respuesta a estímulos y se confirmó su aplicación en cultivos celulares. Los capítulos cinco y seis se centran en una estrategia terapéutica nueva que consiste en potenciar la acción del sistema inmune sobre el tumor para conseguir su eliminación. En el primero de estos capítulos experimentales, se utilizaron nanopartículas MSNs cargadas con el fármaco JQ-1 y un siRNA frente al factor de crecimiento transformante ßeta (TGF-ß) como inmunoterapia. Una vez sintetizadas y caracterizadas, se confirmó la capacidad de estas nanopartículas para llevar a cabo la liberación de los cargos, junto con la disminución en la expresión de PD-L1 y en la producción de TGF-ß. Por último, se confirmó su aplicabilidad al ser capaces de inducir la eliminación de células de melanoma por el sistema inmune. De acuerdo con el último capítulo experimental, se describe un nuevo enfoque inmunoterapéutico basado en la comunicación química. En este caso, empleamos una nanopartícula Janus de oro y sílice funcionalizada con un péptido llamado pHLIP en la cara de sílice y el anticuerpo contra el receptor PD-1 unido a la cara de oro (J-pHLIP-PD1). La membrana de la célula tumoral es decorada por este nanodispositivo y gracias a la exposición del anticuerpo PD-1, se consiguió atrapar a los linfocitos T circulantes, desencadenando la eliminación de células tumorales por el sistema inmunitario. Además, estos resultados se confirmaron en un modelo metastásico B16-F10-Luc con una reducción de nódulos metastáticos. Finalmente, en el capítulo séptimo y octavo, se aborda la discusión general y las conclusiones derivadas de los estudios experimentales presentados en esta tesis doctoral. / [CA] Aquesta tesi doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el disseny, síntesi, caracterització i avaluació de nous nanodispositius híbrids orgànic-inorgànics. En concret, s'han desenvolupat nanopartícules de sílice mesoporoses (MSNs) i nanopartícules Janus combinant MSNs amb platí i amb or per al tractament antitumoral. El primer capítol és una introducció general que inclou una visió global del context on s'emmarca la recerca realitzada. En particular, es presenta informació bàsica sobre les nanopartícules emprades en aquesta tesi doctoral, així com la descripció de la malaltia del càncer i l'aplicació dels nanomaterials com a teràpia. A continuació, al segon capítol, es presenten els objectius generals i específics d'aquesta tesi doctoral. Els capítols tercer i quart descriuen dues estratègies terapèutiques basades en el desenvolupmanet de nanopartícules amb moviment per aconseguir una millora de la terapia antitumoral. Concretament, al primer capítol experimental es presenta un nanodispositiu autopropulsat per a l'alliberament controlat de fàrmacs en resposta al glutatió (GSH) intracel·lular. Aquest es basa en nanopartícules tipus Janus compostes per sílice mesoporosa i or, funcionalitzades a la part de l'or amb l'enzim catalasa, carregades amb doxorrubicina i amb cadenes d'oligo(etilenglicol) (SS-PEG) unides per ponts disulfur a la cara de la sílice. Una vegada sintetitzat i caracteritzat el dispositiu, es va confirmar la seua capacitat de moviment i es va demostrar el funcionament correcte de la porta molecular. Finalment, la internalització cel·lular i l'alliberament de doxorrubicina es van estudiar en cultius cel·lulars. Motivats pels resultats anteriors, al quart capítol es descriu un nanomotor nou dissenyat com a tractament antitumoral i similar a l'anterior. En aquest cas, la nanopartícula Janus desenvolupada està composta per una nanopartícula de sílice mesoporosa juntament amb una de platí, carregada amb doxorrubicina i coberta amb S-S-PEG. Igual que en el treball anterior, s'aconsegueix autopropulsió del dispositiu. A més, es va obtenir el perfil cinètic d'alliberament del càrrec en resposta a estímuls i se'n va confirmar l'aplicació en cultius cel·lulars. Els capítols cinc i sis se centren en una estratègia terapèutica nova que consisteix a potenciar l'acció del sistema immune sobre el tumor per aconseguir-ne l'eliminació. Al primer d'aquests capítols experimentals, es van utilitzar nanopartícules MSNs carregades amb el fàrmac JQ-1 i un siRNA davant del factor de creixement transformant ßeta (TGF-ß) com a immunoteràpia. Un cop sintetitzades i caracteritzades, es va confirmar la capacitat d'aquestes nanopartícules per dur a terme l'alliberament dels càrrecs, juntament amb la disminució de l'expressió de PD-L1 i de la producció de TGF-ß. Finalment, se'n va confirmar l'aplicabilitat en ser capaços d'induir l'eliminació de cèl·lules de melanoma pel sistema immune. D'acord amb el darrer capítol experimental, es descriu un nou enfocament immunoterapèutic basat en la comunicació química. En aquest cas, fem servir una nanopartícula Janus d'or i sílice funcionalitzada amb un pèptid anomenat pHLIP a la cara de sílice i l'anticòs contra el receptor PD-1 unit a la cara d'or (J-pHLIP-PD1). La membrana de la cèl·lula tumoral és decorada per aquest nanodispositiu i gràcies a l'exposició de l'anticòs PD-1, es va aconseguir atrapar els limfòcits T circulants, desencadenant l'eliminació de cèl·lules tumorals pel sistema immunitari. A més, aquests resultats es van confirmar en un model metastàtic B16-F10-Luc amb una reducció de nòduls metastàtics. Finalment, al capítol setè i vuitè, s'aborda la discussió general i les conclusions derivades dels estudis experimentals presentats en aquesta tesi doctoral. / [EN] The present PhD thesis entitled "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" focuses on the design, synthesis, characterization, and evaluation of new hybrid organic-inorganic nanodevices. We have developed mesoporous silica nanoparticles (MSNs) and Janus platinum-MSN and gold-MSN nanoparticles for tumor treatment. The first chapter is a general introduction that includes an overview of the context related to the research developed in this thesis. In particular, it includes basic information about different nanoparticles used in this doctoral thesis along with the description of cancer disease characteristics and the application of nanomaterials as therapy. Next, in the second chapter, the general and specific objectives of this Ph.D. thesis are presented. The third and fourth chapters describe two nanotechnology-based therapeutic strategies based on the development of nanomotors to improve cancer therapy. Specifically, the first experimental chapter presents a self-moving nanodevice for controlled drug release in response to intracellular glutathione (GSH). It is based on Janus gold-mesoporous silica nanoparticles functionalized with the enzyme catalase in the gold face, loaded with doxorubicin and capped with disulfide-linked oligo(ethylene glycol) (S-S-PEG) chains on the silica face. Once synthesized and characterized, the nanosystem motion was confirmed and the proper gating mechanism of the nanodevice was proven. Finally, the cellular uptake and doxorubicin release capacity have been demonstrated in cell cultures. Encouraged by the above results, chapter four describes a similar nanomotor design for antitumor therapy. In this case, the nanoparticle developed is composed of a Janus platinum-mesoporous silica nanoparticle, loaded with doxorubicin, and capped with S-S-PEG. As well as in the previous work, self-propulsion of the nanoparticles was achieved. Moreover, the stimuli-responsive cargo release kinetic profile was obtained and its application was confirmed in cell cultures. Chapters five and six focus on a new therapeutic strategy, empowering the immune system action on tumors to reach tumor cell death. In the first of these experimental chapters, JQ-1 and transforming growth factor-beta (TGF-ß) siRNA-loaded nanoparticles were used as efficient tumor immunotherapy. Once synthesized and characterized, the efficient cargo delivery was accomplished along with the programmed death-ligand 1 (PD-L1) downregulation and TGF-ß silencing. Lastly, its application was confirmed by triggering a specific immunogenic removal of tumor cells in melanoma cells. In chapter six, the development of a new communication-based immunotherapeutic approach is reported. In this case, we employ Janus gold-MSN functionalized with a peptide called pHLIP onto silica face and anti-PD-1 antibody bound to gold face (J-pHLIP-PD1). Tumor cell membrane is decorated by this nanodevice, leaving exposed on the surface PD-1 antibody which catches circulating T lymphocytes. It triggers immune system-induced-tumor leveling. Moreover, J-pHLIP-PD1 treatment-associated reduction of metastatic burden was also proven. Finally, in the seventh and eighth chapter, the general discussion and conclusions derived from the presented experimental studies of this Ph.D. thesis are exposed. / The authors thank the Spanish Government (Projects MAT2015-64139-C4-1, AGL2015-70235-C2-2-R, CTQ2014-58989-P, CTQ2015-71936-REDT and CTQ2017-87954-P) and the Generalitat Valencia (PROMETEO/2018/024) for support. The Comunidad de Madrid (IND2017/BMD-7642) is also gratefully acknowledged. The authors thank the Spanish Government (project PID2021-126304OB-C41, (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO CIPROM/2021/007). E.L-S is grateful for her FPU fellowship funded by MINECO (FPU18/06539). This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). This study forms part of the Advanced Materials program (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON) and by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. / Lucena Sánchez, E. (2024). New advanced anti-tumor therapies based on hybrid mesoporous nanodevices [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/205528

No description available.

Parkinson's disease (PD) is a progressive, neurological movement disorder. The stability of eye movements in PD is not well understood but many patients report difficulty doing tasks that require stabilized fixation and gaze. The ability to stabilize an image on the retina is critical is acquiring visual information. The purpose of this study was to compare the stability of fixational eye movements of PD patients to those of age-matched controls. Eye movements during simple fixation tasks were recorded from 66 subjects (ages 52 to 84), and 36 age-matched controls (ages 58-85). The absolute velocity of the fixational eye movements were recorded and correlated to a clinical measure of disease progression as measured by the Unified Parkinson's Disease Rating Scale (UPDRS). Unstable, non-rhythmic eye movements were seen in the PD patients. There were significant differences in the absolute velocity and standard deviation between the control group and the PD group in both the horizontal and vertical directions. The correlation of the absolute velocity to the UPDRS was not significant. Parkinson's disease does appear to affect the stability of eye movements. The instabilities in the eye movements appear to precede body tremor. This could lead to an early method for diagnosis and analysis of the disease.